63 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting One Week Comparison Study of PTH and PTHrP Infusions
Conditions: Osteoporosis;   Hypercalcemia of Malignancy;   Hyperparathyroidism;   Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36);   Drug: parathyroid hormone (1-34);   Drug: PTH (1-34) and PTHrP (1-36)
22 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
23 Recruiting Studies of Elevated Parathyroid Activity
Conditions: Hyperparathyroidism;   Hypocalcemia;   Hypoparathyroidism;   Parathyroid Neoplasm
Intervention:
24 Recruiting Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
Condition: Secondary Hyperparathyroidism Due to Renal Causes
Interventions: Drug: Paricalcitol;   Drug: Calcifediol
25 Unknown  The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure
Conditions: Hyperparathyroidism;   Hypertension
Intervention: Procedure: parathyroidectomy
26 Recruiting A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary Hyperparathyroidism
Interventions: Drug: ASP7991;   Drug: Cinacalcet;   Drug: Placebo
27 Recruiting To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
28 Not yet recruiting A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
Condition: Hypoparathyroidism
Interventions: Dietary Supplement: amorphous calcium carbonate;   Dietary Supplement: crystalline calcium supplements
29 Recruiting EC17 for Intraoperative Imaging for Parathyroidectomy
Condition: Primary Hyperparathyroidism
Intervention: Drug: EC17
30 Not yet recruiting 11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues
Conditions: Primary Hyperparathyroidism;   Tertiary Hyperparathyroidism
Interventions: Radiation: 11C-Methionine PET/CT scanning;   Radiation: 18F-FDG PET/CT scanning;   Radiation: SPECT-CT scanning
31 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects
Intervention:
32 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
33 Unknown  Lipids Profile in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Intervention:
34 Recruiting The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
Condition: Primary Hyperparathyroidism
Intervention:
35 Not yet recruiting A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Drug: EnteraBio's Oral Parathyroid Hormone (1-34)
36 Recruiting Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
Conditions: Kidney Failure;   Secondary Hyperparathyroidism;   Hyperphosphatemia;   Hypercalcemia
Interventions: Drug: Calcitriol;   Drug: Paricalcitol
37 Recruiting Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Condition: Primary Hyperparathyroidism
Interventions: Drug: Cinacalcet;   Procedure: parathyroid adenomectomy
38 Unknown  Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
Conditions: Stage 5 Chronic Kidney Disease (CKD);   Secondary Hyperparathyroidism (SHPT);   Hemodialysis (HD)
Interventions: Drug: Lunacalcipol 180;   Drug: Lunicalcipol 270
39 Recruiting Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Conditions: Primary Hyperparathyroidism;   Hypercalcemia;   Vitamin D Deficiency;   Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D3
40 Unknown  Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Conditions: Chronic Kidney Disease;   Renal Osteodystrophy;   Left Ventricular Hypertrophy
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years